首页>
外国专利>
Use of gonadoliberin and gonadoliberin agonists in the treatment of metabolic diseases due to too small a parathormone level
Use of gonadoliberin and gonadoliberin agonists in the treatment of metabolic diseases due to too small a parathormone level
展开▼
机译:副激素水平过低导致的性腺激素和性腺激素激动剂在代谢疾病治疗中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
1. Claims (for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE) Pharmaceutical formulation for parenteral administration for the treatment of metabolic disorders which may arise due to the secretion of endogenous parathyroid hormone being too low, which contains 0.5 to less than 5 mu g of gonadoliberin/single dose, or 0.05 to 0.5 mu g of a gonadoliberin agonist/single dose, for an adult of normal weight in a pharmaceutically acceptable vehicle. 1. Claims (for the Contracting State AT) Process for the preparation of a pharmaceutical formulation for parenteral use for the treatment of metabolic disorders which may arise due to the secretion of endogenous parathyroid hormone being too low, containing 0.5 to less than 5 mu g of gonadoliberin/single dose or 0.05 to 0.5 mu g of a gonadoliberin agonist/single dose, for an adult of normal weight, which comprises converting gonadoliberin or its analog, together with a pharmaceutically acceptable vehicle, into a suitable formulation form.
展开▼